Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,839 | 3,525 | 4,268 | 1,337 | 6,234 |
| Receivables | 402 | 237 | 728 | 6,738 | 3,879 |
| Other current assets | 1,165 | 2,209 | 2,209 | 0 | 0 |
| TOTAL | $8,606 | $6,055 | $7,319 | $9,240 | $11,346 |
| Non-Current Assets | |||||
| PPE Net | 371 | 421 | 472 | 2,962 | 3,247 |
| Other Non-Current Assets | 331 | 717 | 728 | 2,390 | 3,149 |
| TOTAL | $702 | $1,138 | $1,200 | $5,352 | $6,396 |
| Total Assets | $9,308 | $7,193 | $8,519 | $14,592 | $17,742 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,486 | 12,061 | 13,190 | 15,014 | 14,017 |
| Accrued Expenses | 2,667 | 2,535 | 2,304 | 1,854 | 834 |
| TOTAL | $12,609 | $15,038 | $15,923 | $17,438 | $15,371 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 422 | 541 | 656 | 1,827 | 1,978 |
| TOTAL | $572 | $811 | $926 | $2,097 | $2,248 |
| Total Liabilities | $13,181 | $15,849 | $16,849 | $19,535 | $17,619 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,306 | 956 | 745 | 250 | 208 |
| Common Shares | 616 | 3 | 3 | 1 | 592 |
| Retained earnings | -396,723 | -395,771 | -394,361 | -386,162 | -380,971 |
| TOTAL | $-3,873 | $-8,656 | $-8,330 | $-4,943 | $123 |
| Total Liabilities And Equity | $9,308 | $7,193 | $8,519 | $14,592 | $17,742 |